---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-038599"
form_type: "8-K"
ticker: "VXRT"
cik: "0000072444"
company_name: "Vaxart, Inc."
filed_at: "2024-12-31T23:59:59+00:00"
generated_at: "2026-05-28T22:33:56.484226+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Vaxart receives second 180-day Nasdaq extension to cure bid price deficiency until June 30, 2025

## Summary
- Nasdaq notified Vaxart on Dec 31, 2024 of an additional 180-day compliance period to meet the $1.00 minimum bid price requirement.
- Extension moves the cure deadline from Dec 30, 2024 to June 30, 2025.
- Company is considering a reverse stock split as a potential cure for the deficiency.
- If not compliant by June 30, 2025, Nasdaq will issue a delisting notice; Vaxart may appeal.

## SEC filing metadata
- accession: 0001437749-24-038599
- form_type: 8-K
- ticker: VXRT
- cik: 0000072444
- company_name: Vaxart, Inc.
- filed_at: 2024-12-31T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/72444/000143774924038599/0001437749-24-038599-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/72444/000143774924038599/vxrt20241231_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-038599
- JSON: https://secwatch.observer/filing/0001437749-24-038599.json
- Plain text: https://secwatch.observer/filing/0001437749-24-038599.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.